Take-home emergency naloxone to prevent deaths from heroin overdose: Time to save lives

BMJ (Online)

Volumn 349, Issue , 2014, Pages

  Strang, John ^a   Bird, Sheila M ^b   Dietze, Paul ^c   Gerra, Gilberto ^d   McLellan, A Thomas ^e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c BURNET INSTITUTE   (Australia)

^d United Nations Office on Drugs and Crime Austria   (Austria)

^e TREATMENT RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; METHADONE; NALOXONE; OPIATE; NARCOTIC ANTAGONIST;

DEATH; DRUG OVERDOSE; EDITORIAL; EMERGENCY TREATMENT; HEROIN DEPENDENCE; HIGH RISK POPULATION; HUMAN; OPIATE ADDICTION; PRISONER; RESUSCITATION; EMERGENCY; EPIDEMIOLOGY; MORTALITY; UNITED KINGDOM;

DRUG OVERDOSE; EMERGENCIES; GREAT BRITAIN; HEROIN DEPENDENCE; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS;

EID: 84910031344     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g6580     Document Type: Editorial

References (14)

1. WHO. Guidelines on community emergency management of opioid overdose. 2014. http: //apps.who.int/iris/bitstream/10665/137462/1/9789241548816-eng.pdf?ua=1.
2. Office of National Statistics. Deaths related to drug poisoning in England and Wales, 2013. www.ons.gov.uk/ons/dcp171778-375498.pdf.
3. Information Services Division. National Naloxone Programme Scotland-naloxone kits issued in 2013/14 and trends in opioid-related deaths. 2014. https://isdscotland.scot.nhs.uk/Health-Topics/Drugs-and-Alcohol-Misuse/Publications/2014-10-28/2014-10-28-Naloxone-Report.pdf?2581423522.
4. Bird SM, Parmar MKB, Strang J. Take-home naloxone to prevent fatalities from opiate-overdose: protocol for Scotland's public health policy evaluation, and a new measure to assess impact. Drugs Educ Prev Policy (forthcoming).
5. Strang J, Darke S, Hall W, Farrell M, Ali R. Heroin overdose: the case for take-home naloxone. BMJ 1996;312:1435-6.
6. Strang J, Kelleher M, Best D, Mayet S, Manning V. Emergency naloxone for heroin overdose-should it be available over the counter? BMJ 2006;333:614-5.
7. UN Office on Drugs and Crime, WHO. Opioid overdose: preventing and reducing opioid overdose mortality. 2013. www.unodc.org/docs/treatment/overdose.pdf.
8. Strang J, Bird SM, Parmar MKB. Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial. J Urban Health 2013;90:983-96.
9. Vilke GM, Sloane C, Smith AM, Chan TC. Assessment for deaths in out-of-hospital heroin overdose patients treated with naloxone who refuse transport. Acad Emerg Med 2003;10:893-6.
10. Rudolph SS, Jehu G, Nielsen SL, Nielsen K, Siersma V, Rasmussen LS. Prehospital treatment of opioid overdose in Copenhagen-is it safe to discharge on-scene? Resuscitation 2011;82:1414-8.
11. Wanger K, Brough L, Macmillan I, Goulding J, MacPhail I, Christenson JM. Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose. Acad Emerg Med 1998;5:293-9.
12. Cornish R, Macleod J, Strang J, Vickerman P, Hickman M. Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database. BMJ 2010;341:c5475.
13. Merrall EL, Kariminia A, Binswanger IA, Hobbs MS, Farrell M, Marsden J, et al. Meta-analysis of drug-related deaths soon after release from prison. Addiction 2010;105:1545-54.
14. Merrall EL, Bird SM, Hutchinson SJ. A record-linkage study of drug-related death and suicide after hospital discharge among drug-treatment clients in Scotland, 1996-2006.Addiction 2013;108:377-84.